Both in Pharmaceuticals
ADC Therapeutics SA vs Minerva Neurosciences
Over the past year ADCT returned −69.4% and NERV returned +59.5%; their daily moves had a correlation of -0.03.
ADCT −69.4% NERV +59.5%Growth of $1, one year, split-adjusted
| Metric | ADCT | NERV |
|---|---|---|
| Price | $1.23 | $3.35 |
| Market cap | $157.0M | $160.0M |
| Today | −2.38% | −1.47% |
| 1 month | +7.9% | −30.8% |
| 6 months | −66.2% | −43.9% |
| Year to date | −65.2% | −16.7% |
| 1 year | −66.3% | +58.0% |
| Revenue growth (YoY) | +2.2% | — |
| Gross margin | 87.8% | — |
| Net margin | −86.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.0× | — |
| Net cash | $102.5M | $75.3M |
| Dividend yield | — | — |
| Volatility (60d) | 77.0% | 77.9% |
| Short % of float | 5.4% | 6.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).